InvestorsHub Logo
Followers 86
Posts 25803
Boards Moderated 0
Alias Born 09/15/2003

Re: None

Monday, 03/28/2016 9:23:15 AM

Monday, March 28, 2016 9:23:15 AM

Post# of 651
"Dr. Tamar Ben-Yedidia, BiondVax's Chief Scientist, explained, "This important milestone, along with the NIH-sponsored Phase 2 trial in the USA, keeps BiondVax on track to be Phase 3 ready by 2017/18. We are excited to be one step closer to bringing our multi-strain and multi-season vaccine against seasonal and pandemic flu to the market."

Prof. Dr. Eelko Hak, UNISEC clinical trial program work package leader, commented, "This important clinical trial is a major contribution to the mission of the European UNISEC consortium to learn more about the potential of these promising broadly reactive new vaccines.""
http://finance.yahoo.com/news/biondvaxs-universal-flu-vaccine-phase-130000523.html

1/2 cent Vancouver penny mooching pirates!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BVXV News